BlackRock, Inc. ownership in 37T / Forte Biosciences, Inc.

Forte Biosciences, Inc.

DE ˙ DB

14,40 € ↓ -0,80 (-5,26%)

2026-06-04
PREZZO DELLE AZIONI

Security	DE:37T / Forte Biosciences, Inc.
Institution	BlackRock, Inc.
Latest Disclosed Ownership	214,043 shares
Ownership	1.50%

2022-07-08 - BlackRock, Inc. has filed an SC 13G form with the Securities and Exchange Commission (SEC) disclosing ownership of 214,043 shares of Forte Biosciences, Inc. (DE:37T). This represents 1.5 percent ownership of the company. In their previous filing dated 2022-02-04 , BlackRock, Inc. had reported owning 817,063 shares, indicating a decrease of -73.80 percent.

Institutional Ownership: 13D/G Filings

This table shows a history of the 13D/G filings made by the investor and/or investor group. Note that the share values in this table are not directly comparable to any numbers shown in the 13F table (if any).

File Date	Effective Date	Form	Prev Shares	Latest Shares	ΔShares (Percent)	Ownership (Percent)	ΔOwnership (Percent)
2022-07-08	2022-07-08	13G	817,063	214,043	-73.80	1.50	-72.73
2022-02-04	2022-02-04	13G	49,441	817,063	1,552.60	5.50	1,000.00
2020-07-10	2020-07-10	13G/A		49,441		0.50
2020-02-06	2020-02-06	13G/A	1,501,501	1,695,370	12.91	7.10	9.23
2019-02-06	2019-02-06	13G/A	1,069,152	1,501,501	40.44	6.50	20.37
2018-02-01	2018-02-01	13G		1,069,152		5.40

Important Note: One of the primary uses of the 13D/G filings is to evaluate the ability of a firm to control a company (ie, the "beneficial ownership"). To that end, firms are required to report not just direct holdings in companies, but indirect holdings that they control. For investment firms, these indirect holdings can include shares in funds they manage, advisory accounts, and in the case of activist campaigns, pledged votes. Therefore, share counts listed in 13D/G filings can differ significantly than share counts listed in 13F filings.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel Premium Registration Required .

Disclosed Equity Positions (from 13F/NPORT Filings)

File Date	Effective Date	Form	Security	Class	ID	Reported Shares	ΔShares	ΔShares (%)	Reported Value (x1000)	ΔValue (%)	Alloc (%)
2026-05-13	2026-03-31	13F	FORTE BIOSCIENCES	COM NEW	34962G208	65,921	1,425	2.21	1,707	-2.90	0.0000
2026-02-12	2025-12-31	13F	FORTE BIOSCIENCES	COM NEW	34962G208	64,496	13,834	27.31	1,759	131.62	0.0000
2025-11-12	2025-09-30	13F	FORTE BIOSCIENCES	COM NEW	34962G208	50,662	16,967	50.35	760	74.48	0.0000
2025-08-12	2025-06-30	13F	FORTE BIOSCIENCES	COM NEW	34962G208	33,695	26,892	395.30	436	736.54	0.0000
2025-05-02	2025-03-31	13F	FORTE BIOSCIENCES	COM NEW	34962G208	6,803	0	0.00	53	-66.23	0.0000
2025-02-07	2024-12-31	13F	FORTE BIOSCIENCES	COM NEW	34962G208	6,803	0	0.00	154	305.26	0.0000
2024-11-13	2024-09-30	13F	FORTE BIOSCIENCES	COM NEW	34962G208	6,803	-1,663,252	-99.59	38	-98.13	0.0000
2020-05-01	2020-03-31	13F	TOCAGEN	COM	888846102	1,670,055	-25,315	-1.49	2,037	125.58	0.0001
2020-02-13	2019-12-31	13F	TOCAGEN	COM	888846102	1,695,370	85,401	5.30	903	-15.29	0.0000
2019-11-08	2019-09-30	13F	TOCAGEN	COM	888846102	1,609,969	-62,196	-3.72	1,066	-90.46	0.0000
2019-08-22	2019-06-30	13F/A-1	TOCAGEN	COM	888846102	1,672,165	11,152	0.67	11,171	-38.13	0.0005
2019-08-13	2019-06-30	13F	TOCAGEN	COM	888846102	1,672,165	11,152		11,171
2019-05-09	2019-03-31	13F	TOCAGEN	COM	888846102	1,661,013	159,512	10.62	18,055	46.47	0.0008
2019-02-08	2018-12-31	13F	TOCAGEN	COM	888846102	1,501,501	88,216	6.24	12,327	-44.05	0.0006
2018-11-09	2018-09-30	13F	TOCAGEN	COM	888846102	1,413,285	284,518	25.21	22,033	109.00	0.0010
2018-08-09	2018-06-30	13F	TOCAGEN	COM	888846102	1,128,767	62,351	5.85	10,542	-16.58	0.0005
2018-05-09	2018-03-31	13F	TOCAGEN	COM	888846102	1,066,416	-2,736	-0.26	12,637	15.30	0.0006
2018-02-09	2017-12-31	13F	TOCAGEN	COM	888846102	1,069,152	285,396	36.41	10,960	12.21	0.0005
2017-11-14	2017-09-30	13F	TOCAGEN	COM	888846102	783,756	8,828	1.14	9,767	4.76	0.0005
2017-08-10	2017-06-30	13F	TOCAGEN	COM	888846102	774,928	774,928		9,323		0.0005

Legend

Shares: The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value: The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price: The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class: This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred

Allocation (%): The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation: The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%): The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis: The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss: This is the market value of the position as of the effective date minus the cost basis.